ADMA Biologics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADMA Nasdaq 2836 https://www.admabiologics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADMA Biologics Inc

ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023 - Mar 16th, 2023 11:00 am
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Profit Outlook - Mar 3rd, 2023 2:48 pm
Allogene (ALLO) Incurs Narrower-Than-Expected Loss in Q4 - Mar 1st, 2023 2:36 pm
BioMarin (BMRN) Q4 Earnings Miss, Sales Beat, Stock Down - Feb 28th, 2023 2:10 pm
7 A-Rated Penny Stocks Worth Betting On - Feb 19th, 2023 7:05 pm
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine - Feb 12th, 2023 3:56 pm
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA - Feb 8th, 2023 12:00 pm
Sage and Biogen's NDA for Depression Drug Gets Priority Review - Feb 7th, 2023 3:17 pm
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance - Jan 17th, 2023 12:00 pm
12 Best Performing NASDAQ Stocks in 2022 - Dec 29th, 2022 4:58 am
12 Best Performing Biotech Stocks in 2022 - Dec 29th, 2022 3:15 am
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM® - Dec 13th, 2022 12:00 pm
Adam Grossman Is The Co-Founder of ADMA Biologics, Inc. (NASDAQ:ADMA) And They Just Picked Up 1.2% More Shares - Dec 11th, 2022 1:41 pm
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Dec 9th, 2022 9:05 pm
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock - Dec 7th, 2022 1:45 pm
ADMA Biologics Announces Proposed Public Offering of Common Stock - Dec 6th, 2022 9:05 pm
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate - Dec 6th, 2022 9:01 pm
ADMA Biologics Third Quarter 2022 Earnings: Beats Expectations - Nov 11th, 2022 10:28 am
Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates - Nov 9th, 2022 10:35 pm
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update - Nov 9th, 2022 9:05 pm